2025.02.13
来源:AgroPages (World Agrochemical Network)
作者:Wang Zhenguo
AgroPages Chinese WebsiteReport: In January 2025, the Heilongjiang Provincial Department of Agriculture and Rural Affairs approved the applications for expanding pesticide production licenses of Heilongjiang Lianshun Biotechnology Co., Ltd. and Heilongjiang Xintai Biotechnology Co., Ltd. Both companies, together with the industry-renowned Ningxia Taiyixin, are subsidiaries of Duowei Pharmaceutical Group. The specific production licenses approved are as follows:
Affiliated Enterprise 1:
Manufacturing Enterprise Name: Heilongjiang Lianshun Biotechnology Co., Ltd.
License Number: Pesticide Production License (Heilongjiang) 0047
Domicile/Production Address: Xinli Village, Zhongxinhe Township, Qiezihe District, Qitaihe City, Heilongjiang Province (Jianghe Ronghe Green Intelligent Industrial Park)
Production Scope:
Technical grade (mother drug) varieties include emamectin benzoate, avermectin, pymetrozine, tebuconazole, and prochloraz.
Valid Until: December 8, 2026
Newly Added Technical Grade Varieties: Pymetrozine, tebuconazole, prochloraz.

Affiliated Enterprise 2:
Manufacturing Enterprise Name: Heilongjiang Xintai Biotechnology Co., Ltd.
License Number: Pesticide Production License (Heilongjiang) 0050
Domicile/Production Address: Xinli Village, Zhongxinhe Township, Qiezihe District, Qitaihe City, Heilongjiang Province (Jianghe Ronghe Green Intelligent Industrial Park)
Production Scope: Technical grade (mother drug) varieties include indoxacarb, thiamethoxam, spirotetramat, and boscalid.
Formulations (chemical pesticides): soluble solutions, water agents.
Valid until: February 5, 2029
Newly added technical grade (mother drug) varieties: indoxacarb, thiamethoxam, spirotetramat, boscalid.

As an important member of Duowei Group's pesticide division, Ningxia Taiyixin has deeply engaged in the fields of avermectin and emamectin benzoate for many years, enjoying a high reputation in the industry. The addition of production qualifications for multiple key varieties at Duowei's Heilongjiang base, combined with the glyphosate and glufosinate-ammonium technical grade varieties expanded by Ningxia Taiyixin in 2019, will effectively enrich the group's product line. It is understood that the expansion of other technical grade pesticide varieties in the group's pesticide division is still ongoing, with full efforts to provide more comprehensive agrochemical input solutions for agricultural production.
Founded on June 21, 2019, Heilongjiang Lianshun Biotechnology Co., Ltd. is located in the Jianghe Ronghe Green Intelligent Manufacturing Industrial Park in Qitaihe City, Heilongjiang Province. With a registered capital of 4.066 billion yuan, a total planned investment of 12 billion yuan, and a land area of approximately 5,000 mu, it demonstrates Duowei Pharmaceutical Group's firm confidence in laying out the pesticide industry.
In 2024, the technical pesticide market remained sluggish under the combined effect of multiple factors, including oversupply, declining raw material prices, weak demand, impacts of environmental protection policies, intensified market competition, changes in the international trade environment, technological advancements, and inventory pressure. According to the technical pesticide price index of Sinon AgriChem at the end of 2024, the technical pesticide price index stood at 72.96 points by the end of 2024, a year-on-year decrease of 9.62%. Among the hundreds of tracked products, 65% saw year-on-year price declines.
In the first quarter of 2025, amid the violent fluctuations in the veterinary drug raw material market, the price curve of tylosin tartrate showed a steep upward trend. As of March 21, the quotation of tylosin tartrate from Ningxia Taiyixin Biotechnology has reached 290 yuan per kilogram (with an actual market transaction price of 280 yuan per kilogram), a cumulative increase of 23.5% from the benchmark price at the beginning of the year, hitting a price peak for this product category in nearly two years. This market aberration seemingly triggered by production capacity contraction actually reflects the deep-seated transformation of China's veterinary drug industry from extensive expansion to a model driven by high-end brands and technology.
In the pharmaceutical and veterinary drug raw material markets, the price trend of lincomycin hydrochloride has always attracted significant attention. As a broad-spectrum antibiotic, lincomycin hydrochloride holds a crucial position in both clinical treatment and livestock and poultry farming. In recent years, its price has shown a remarkable upward trend, and various signs indicate that this trend will continue in the future, with the potential to even break through historical high prices.
在银川举行的第十二届农药行业经济运行分析会上,一则喜讯振奋人心—— 宁夏泰益欣生物科技股份有限公司荣膺 2024 农药行业年度排名第 19 位,销售额高达 37.58 亿元。这一傲人成绩,无疑是泰益欣在农药领域深耕细作、持续创新的有力见证,也为整个行业发展注入了一剂 “强心针” 。